Chen Qiyu and Xu Xiaoliang, Co-CEOs of Fosun International win Asia's Best CEO from Corporate Governance Asia Fosun ...
Results of the ongoing eNRGy trial, a single-arm, multicenter, global phase 2 clinical trial evaluating zenocutuzumab in solid tumors positive for Neuregulin 1 (NRG1) gene fusions, reported manageable ...
A new study led by researchers at The University of Texas MD Anderson Cancer Center has identified a way to tailor drug ...
Morning Overview on MSN
The FDA cleared a breast cancer drug that added five months of survival for hard-to-treat tumors
Women diagnosed with advanced triple-negative breast cancer who cannot receive immunotherapy now have a new first-line ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results